1. Home
  2. ONTF vs GNFT Comparison

ONTF vs GNFT Comparison

Compare ONTF & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONTF
  • GNFT
  • Stock Information
  • Founded
  • ONTF 1998
  • GNFT 1999
  • Country
  • ONTF United States
  • GNFT France
  • Employees
  • ONTF N/A
  • GNFT N/A
  • Industry
  • ONTF Computer Software: Prepackaged Software
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ONTF Technology
  • GNFT Health Care
  • Exchange
  • ONTF Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • ONTF 230.2M
  • GNFT 186.3M
  • IPO Year
  • ONTF 2021
  • GNFT 2019
  • Fundamental
  • Price
  • ONTF $5.47
  • GNFT $4.25
  • Analyst Decision
  • ONTF Hold
  • GNFT Strong Buy
  • Analyst Count
  • ONTF 4
  • GNFT 2
  • Target Price
  • ONTF $5.33
  • GNFT $11.00
  • AVG Volume (30 Days)
  • ONTF 140.9K
  • GNFT 2.7K
  • Earning Date
  • ONTF 11-06-2025
  • GNFT 09-22-2025
  • Dividend Yield
  • ONTF N/A
  • GNFT N/A
  • EPS Growth
  • ONTF N/A
  • GNFT N/A
  • EPS
  • ONTF N/A
  • GNFT 0.03
  • Revenue
  • ONTF $143,071,000.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • ONTF N/A
  • GNFT $5.15
  • Revenue Next Year
  • ONTF N/A
  • GNFT N/A
  • P/E Ratio
  • ONTF N/A
  • GNFT $134.73
  • Revenue Growth
  • ONTF N/A
  • GNFT 105.01
  • 52 Week Low
  • ONTF $4.35
  • GNFT $2.55
  • 52 Week High
  • ONTF $7.04
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • ONTF 52.28
  • GNFT 56.17
  • Support Level
  • ONTF $5.40
  • GNFT $3.91
  • Resistance Level
  • ONTF $5.64
  • GNFT $4.27
  • Average True Range (ATR)
  • ONTF 0.15
  • GNFT 0.13
  • MACD
  • ONTF -0.01
  • GNFT 0.01
  • Stochastic Oscillator
  • ONTF 23.66
  • GNFT 81.47

About ONTF ON24 Inc.

ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The Company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: